Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DMPXW12)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
monocrotaline; 315-22-0; Crotaline; Monocrotalin; NSC 28693; CCRIS 416; (-)-Monocrotaline; UNII-73077K8HYV; HSDB 3513; Retronecine cyclic 2,3-dihydroxy-2,3,4-trimethylglutarate; BRN 0048732; (13-alpha,14-alpha)-14,19-Dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dione; CHEBI:6980; 14,19-Dihydro-12,13-dihydroxy-20-norcrotolanan-11,15-dione; QVCMHGGNRFRMAD-XFGHUUIASA-N; 73077K8HYV; 20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13alpha,14alpha)-
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Breast
Breast adenocarcinoma
Kidney
Normal (Immortalized)
Prostate
Prostate carcinoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
